CHELSEY LINDAUER: Open Payments
NPI 1043736648 · W AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 62 payments from 17 companies in 2025. Trend: 2023 $1,497 · 2024 $1,041 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $269 |
| Novo Nordisk Inc | 10 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| GlaxoSmithKline, LLC. | 5 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| PFIZER INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| ABBVIE INC. | 3 | $71 |
| Exact Sciences Corporation | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
Products named: MOUNJARO, ZEPBOUND, Wegovy, Kerendia, JARDIANCE, CAPLYTA, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
